drugset / Trial / NCT07030504
To Evaluate the Safety, Tolerability and Pharmacokinetic of SAL0133 Tablets in Chinese Adult Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the safety and tolerance of single and multiple administrations of SAL0133 tablets in adult healthy subjects in China receptivity.
Timeline
- Start
- 2023-01-10
- Primary completion
- 2025-06
- Completion
- 2025-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAL0133 | Unknown | 50 mg | — |
| Subject | SAL0133 | Unknown | 150 mg | — |
| Subject | SAL0133 | Unknown | 300 mg | — |
| Subject | SAL0133 | Unknown | 600 mg | — |
Indications
No indication recorded.